Skip to main content

Table 3 Definition of population analysis sets

From: Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan

Analysis population

Early pharmacological treatment group

Expectant management group

Intention-to-treat

‘as randomised’

Early pharmacological treatment randomisation:

Including all protocol deviations.

Expectant management randomisation:

Including all protocol deviations.

Per-protocol

Early pharmacological treatment randomisation and treated according to study protocol:

Excluding other protocol deviations.

Expectant management randomisation and treated according to study protocol:

Including those patients who received ‘open label’ pharmacological treatment and fulfilled the ‘open label’ criteria as described in the protcol; Excluding those patients who received ‘open label’ treatment not according to ‘open label’ criteria in study protocol; Excluding other protocol deviations.